BIIB Biogen Inc.

track record → $185.95 +2.61 (+1.4%)
Get emailed when BIIB changes direction
Mkt Cap $26B P/E 20.2 fwd 11.2 52wk $115.25 - $202.41 Earnings 2026-04-29
Factor Model (net -1.5)

Factor Model

net -1.5
Est. Revisions
-0.1
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0

Analysis pending — waiting for first signal cycle.

Evidence

1d ago Wells Fargo up BIIB: Equal-Weight → Overweight
7d ago Piper Sandler up BIIB: Neutral → Overweight
8d ago Insider buy by DORSA CAROLINE D (BIIB): $151,559
8d ago Insider buy by MURPHY NICOLE (BIIB): $585
8d ago Citigroup main BIIB: Neutral → Neutral
8d ago Truist Securities main BIIB: Hold → Hold
Fundamentals & Data ▾
Biogen Inc. Healthcare · Drug Manufacturers - General
Mkt Cap
$26B
P/E
20.2 fwd 11.2
Beta
0.16
52w Range
$115.25 - $202.41
Short Interest
3.8M 3.37%
Days to Cover
4.0 -9%
Technicals downtrend
from 52w Hi
0.0%
1w return
+3.9%
Insiders
selling 0B / 3S
Analysts
bullish 2 up / 0 down
EPS Estimate
$3.01 -1.2% 30d 0up / 4dn
Est. Dispersion
100% 25 analysts
Analyst Target
$208 $150 - $275
Options P/C
0.23
Insider Cluster
buy cluster 2B / 3S
Fund Convergence
strong D.E. Shaw, Citadel, Renaissance, Two Sigma
Financials
Revenue
$2.3B -7% YoY
FCF
$402M
Gross Margin
78%
Op Margin
17%
Momentum: decelerating
Top Holders
D.E. Shaw $625M
Citadel $107M
Renaissance $70M
Two Sigma $2M
Recent Filings & Data
insider trade 66
net selling · $2,934,776 sold · $152,144 bought
20 insiders · 66 transactions (30d)
Recent transactions
SINGHAL PRIYA · sell · $17,293
KRAMER ROBIN C. · other
SINGHAL PRIYA · other
GODBOUT SEAN · other
MURPHY NICOLE · buy · $585
SINGHAL PRIYA · sell · $531,548
GROGAN JANE · other
GODBOUT SEAN · other
VIEHBACHER CHRISTOPHER · other
IZZAR RACHID · other
MURPHY NICOLE · other
KEENEY ADAM JAMES · other
ALEXANDER SUSAN H · other
GREGORY GINGER · other
SINGHAL PRIYA · sell · $134,116
SINGHAL PRIYA · other
VIEHBACHER CHRISTOPHER · other
GROGAN JANE · other
GODBOUT SEAN · other
SINGHAL PRIYA · sell · $69,045
SINGHAL PRIYA · other
IZZAR RACHID · sell · $300,105
LANGER SUSAN · award
MINOR LLOYD B. · award
MANTAS JESUS B · award
PATOLAWALA MONISH D · award
ROWINSKY ERIC K. · award
FREIRE MARIA C · award
HAWKINS WILLIAM A III · award
SHERWIN STEPHEN A · award
DORSA CAROLINE D · award
SINGHAL PRIYA · sell · $480,508
DORSA CAROLINE D · buy · $151,559
KEENEY ADAM JAMES · other
SHERWIN STEPHEN A · sell · $1,314,142
KRAMER ROBIN C. · other
SINGHAL PRIYA · other
MCDONNELL MICHAEL R · other
IZZAR RACHID · other
MURPHY NICOLE · other
ALEXANDER SUSAN H · other
GREGORY GINGER · other
GROGAN JANE · other
KRAMER ROBIN C. · other
SINGHAL PRIYA · other
VIEHBACHER CHRISTOPHER · other
MCDONNELL MICHAEL R · other
IZZAR RACHID · other
MURPHY NICOLE · other
KEENEY ADAM JAMES · other
ALEXANDER SUSAN H · other
GREGORY GINGER · other
SINGHAL PRIYA · other
FREIRE MARIA C · award
HAWKINS WILLIAM A III · award
SHERWIN STEPHEN A · award
DORSA CAROLINE D · award
KRAMER ROBIN C. · other
SINGHAL PRIYA · other
ALEXANDER SUSAN H · other
SINGHAL PRIYA · sell · $88,019
SINGHAL PRIYA · other
LANGER SUSAN · award
MANTAS JESUS B · award
PATOLAWALA MONISH D · award
ROWINSKY ERIC K. · award
analyst rating 4
Wells Fargo up → Overweight 1d ago
Piper Sandler up → Overweight 7d ago
7 signals · latest 1d ago

Get alerted when BIIB changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.